Juan F Burgueño, Julia Fritsch, Eddy E González, Kevin S Landau, Ana M Santander, Irina Fernández, Hajar Hazime, Julie M Davies, Rebeca Santaolalla, Matthew C Phillips, Sophia Diaz, Rishu Dheer, Nivis Brito, Judith Pignac-Kobinger, Ester Fernández, Gregory E Conner, Maria T Abreu
BACKGROUND & AIMS: Chronic colonic inflammation leads to dysplasia and cancer in patients with inflammatory bowel disease. We have described the critical role of innate immune signaling via Toll-like receptor 4 (TLR4) in the pathogenesis of dysplasia and cancer. In the current study, we interrogate the intersection of TLR4 signaling, epithelial redox activity, and the microbiota in colitis-associated neoplasia. METHODS: Inflammatory bowel disease and colorectal cancer data sets were analyzed for expression of TLR4, dual oxidase 2 (DUOX2), and NADPH oxidase 1 (NOX1)...
February 2021: Gastroenterology